Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.
暂无分享,去创建一个
K. Brown | J. Ix | M. Schwarz | T. King | F. McCormack | A. Kervitsky | B. Kinder
[1] K. Brown,et al. Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. , 2008, Chest.
[2] D. Hansell,et al. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. , 2007, Arthritis and rheumatism.
[3] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[4] F. Martinez,et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. , 2006, American journal of respiratory and critical care medicine.
[5] Johny Verschakelen,et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. , 2005, The New England journal of medicine.
[6] Charles E. McCulloch,et al. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models , 2005 .
[7] M. Mejía,et al. Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis. , 2004, Chest.
[8] G. Raghu,et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. , 2004, The New England journal of medicine.
[9] F. Martinez,et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. , 2003, American journal of respiratory and critical care medicine.
[10] H. Collard,et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[11] A. Nicholson,et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. , 2003, American journal of respiratory and critical care medicine.
[12] M. Matthay,et al. Prognostic value of surfactant proteins A and D in patients with acute lung injury* , 2003, Critical care medicine.
[13] H. Mukae,et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia , 2003, Thorax.
[14] U. Costabel,et al. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias , 2002, European Respiratory Journal.
[15] G. Hunninghake,et al. Serum surfactant proteins‐A and ‐D as biomarkers in idiopathic pulmonary fibrosis , 2002, European Respiratory Journal.
[16] Paul J. Friedman,et al. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.
[17] J. Tooze,et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.
[18] W. Thurlbeck,et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. , 2001, American journal of respiratory and critical care medicine.
[19] A. Nicholson,et al. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. , 2000, American journal of respiratory and critical care medicine.
[20] S. Abe,et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. , 2000, American journal of respiratory and critical care medicine.
[21] David A. Lynch,et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .
[22] J. Whitsett,et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. , 1999, American journal of respiratory and critical care medicine.
[23] P. Parsons,et al. Serum surfactant protein-A levels predict development of ARDS in at-risk patients. , 1999, Chest.
[24] J. Myers,et al. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.
[25] K P Offord,et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.
[26] D. Hansell,et al. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography. , 1997, Arthritis and rheumatism.
[27] R. McFadden. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. , 1996, American journal of respiratory and critical care medicine.
[28] T. King,et al. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. , 1995, American journal of respiratory and critical care medicine.